{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T06:33:18Z","timestamp":1793082798639,"version":"4.5.0"},"reference-count":215,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.pbb.2024.173858","type":"journal-article","created":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T17:16:37Z","timestamp":1724346997000},"page":"173858","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["ANXIOLYTICS: Origins, drug discovery, and mechanisms"],"prefix":"10.1016","volume":"245","author":[{"given":"Jeffrey M.","family":"Witkin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James E.","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2024.173858_bb0005","first-page":"900","article-title":"Lu-AA21004, a multimodal serotonergic agent, for the potential treatment of depression and anxiety","volume":"13","author":"Adell","year":"2010","journal-title":"IDrugs"},{"issue":"6","key":"10.1016\/j.pbb.2024.173858_bb0010","first-page":"1749","article-title":"Revealing analgesic and anxiolytic potentials of synthetic benzimidazole analogues: an in-vivo and in-silico study","volume":"36","author":"Akhtar","year":"2023","journal-title":"Pak. J. Pharm. Sci."},{"key":"10.1016\/j.pbb.2024.173858_bb0015","doi-asserted-by":"crossref","first-page":"117597","DOI":"10.1016\/j.jep.2023.117597","article-title":"Assessment of the anxiolytic, antidepressant, and antioxidant potential of Parquetina nigrescens (Afzel.) Bullock in Wistar rats","volume":"322","author":"Akinduko","year":"2024","journal-title":"J. Ethnopharmacol."},{"issue":"7","key":"10.1016\/j.pbb.2024.173858_bb0025","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.neuropharm.2007.02.005","article-title":"Anxiolytic-like effects through a GLUK5 kainate receptor mechanism","volume":"52","author":"Alt","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2024.173858_bb0030","doi-asserted-by":"crossref","first-page":"114506","DOI":"10.1016\/j.physbeh.2024.114506","article-title":"Additive anxiolytic-like effect of citicoline and ACPA in the non-acute restraint stress (NARS) and acute restraint stress (ARS) mice","volume":"277","author":"Amnzade","year":"2024","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.pbb.2024.173858_bb0035","doi-asserted-by":"crossref","first-page":"175854","DOI":"10.1016\/j.ejphar.2023.175854","article-title":"Coronaridine congeners induce sedative and anxiolytic-like activity in na\u00efve and stressed\/anxious mice by allosteric mechanisms involving increased GABAA receptor affinity for GABA","volume":"953","author":"Arias","year":"2023","journal-title":"Eur. J. Pharmacol."},{"issue":"13","key":"10.1016\/j.pbb.2024.173858_bb0040","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1001\/jama.1979.03300130045021","article-title":"Benzodiazepines: dependence and withdrawal","volume":"242","author":"Ayd","year":"1979","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.pbb.2024.173858_bb0045","first-page":"236","article-title":"The investigation of antidepressant and anxiolytic effects of pregabalin and its mechanisms of action in rats","volume":"35","author":"Ayd\u0131n","year":"2023","journal-title":"Agri"},{"key":"10.1016\/j.pbb.2024.173858_bb0050","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1177\/0269881108089603","article-title":"A comparison of the effects of a subtype selective and non-selective benzodiazepine receptor agonist in two CO(2) models of experimental human anxiety","volume":"23","author":"Bailey","year":"2009","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pbb.2024.173858_bb0055","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.bbr.2018.12.019","article-title":"Evaluation of 5-HT7 receptor antagonism for the treatment of anxiety, depression, and schizophrenia through the use of receptor-deficient mice","volume":"360","author":"Balcer","year":"2019","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pbb.2024.173858_bb0060","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1136\/bmj.d1199","article-title":"Efficacy of drug treatments for generalised anxiety disorder: systematic review and meta-analysis","volume":"342","author":"Baldwin","year":"2011","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.pbb.2024.173858_bb0065","doi-asserted-by":"crossref","first-page":"327","DOI":"10.31887\/DCNS.2015.17.3\/bbandelow","article-title":"Epidemiology of anxiety disorders in the 21st century","volume":"17","author":"Bandelow","year":"2015","journal-title":"Dialogues Clin. Neurosci."},{"issue":"1","key":"10.1016\/j.pbb.2024.173858_bb5005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02247357","article-title":"5-HT receptors as targets for the development of novel anxiolytic drugs: models, mechanisms and future directions","volume":"112","author":"Barrett","year":"1993","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2024.173858_bb0070","series-title":"Buspirone: Mechanisms and Clinical Aspects","first-page":"37","article-title":"Buspirone in animal models of anxiety","author":"Barrett","year":"1991"},{"issue":"3","key":"10.1016\/j.pbb.2024.173858_bb0075","first-page":"554","article-title":"Behavioral studies with anxiolytic drugs. I. Interactions of the benzodiazepine antagonist Ro 15-1788 with chlordiazepoxide, pentobarbital and ethanol","volume":"233","author":"Barrett","year":"1985","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.pbb.2024.173858_bb0080","first-page":"1009","article-title":"Behavioral studies with anxiolytic drugs. III. Antipunishment actions of buspirone in the pigeon do not involve benzodiazepine receptor mechanisms","volume":"238","author":"Barrett","year":"1986","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.pbb.2024.173858_bb0085","first-page":"80","article-title":"Half of the patients with subepithelial tumors present borderline or pathologic anxiety-distress and carcinophobia: a multicenter cohort study","volume":"115","author":"Bas-Cutrina","year":"2023","journal-title":"Rev. Esp. Enferm. Dig."},{"issue":"6","key":"10.1016\/j.pbb.2024.173858_bb5010","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1007\/s10517-023-05944-6","article-title":"Influence of a Nitric Oxide Synthase Inhibitor on the Anxiolytic, Stimulating, and Analgesic Effects of Long-Term Perinatal Caffeine Exposure in Rats","volume":"Oct;175","author":"Bashkatova","year":"2023","journal-title":"Bull. Exp. Biol. Med."},{"issue":"5","key":"10.1016\/j.pbb.2024.173858_bb0090","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1017\/S003329171200147X","article-title":"Global prevalence of anxiety disorders: a systematic review and meta-regression","volume":"43","author":"Baxter","year":"2013","journal-title":"Psychol. Med."},{"key":"10.1016\/j.pbb.2024.173858_bb0095","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0091-3057(98)00180-4","article-title":"Effects of chronic antidepressants in an operant conflict procedure of anxiety in the rat","volume":"62","author":"Beaufour","year":"1999","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"4","key":"10.1016\/j.pbb.2024.173858_bb0100","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/j.1552-4604.1994.tb02002.x","article-title":"A placebo-controlled evaluation of single, escalating doses of CL 284,846, a non-benzodiazepine hypnotic","volume":"34","author":"Beer","year":"1994","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.pbb.2024.173858_bb0105","first-page":"1108","article-title":"Rodent models of anxiety-like behaviors: are they predictive for compounds acting via non-benzodiazepine mechanisms?","volume":"2","author":"Belzung","year":"2001","journal-title":"Curr. Opin. Investig. Drugs"},{"issue":"5\u20136","key":"10.1016\/j.pbb.2024.173858_bb0110","first-page":"645","article-title":"Modeling specific phobias and posttraumatic stress disorder in rodents: the challenge to convey both cognitive and emotional features","volume":"23","author":"Berardi","year":"2012","journal-title":"Rev. Neurosci."},{"issue":"4","key":"10.1016\/j.pbb.2024.173858_bb0115","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1476-5381.1947.tb00341.x","article-title":"The mode of action of myanesin","volume":"2","author":"Berger","year":"1947","journal-title":"Br. J. Pharmacol. Chemother."},{"key":"10.1016\/j.pbb.2024.173858_bb0120","doi-asserted-by":"crossref","DOI":"10.1111\/j.1476-5381.1946.tb00046.x","article-title":"The pharmacological properties of \u03b1:\u03b2-dihydroxy-\u03b3-(2-methylphenoxy)-propane (myanesin)","author":"Berger","year":"1946","journal-title":"Br J Pharmacol Chemother."},{"key":"10.1016\/j.pbb.2024.173858_bb0125","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/nrd.2016.88","article-title":"Failed trials for central nervous system disorders do not necessarily invalidate preclinical models and drug targets","volume":"15","author":"Bespalov","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.pbb.2024.173858_bb0130","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jpsychires.2023.05.046","article-title":"Mix of almond baru (Dipteryx alata Vog.) and goat whey modulated intestinal microbiota, improved memory and induced anxiolytic like behavior in aged rats","volume":"164","author":"Bid\u00f4","year":"2023","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.pbb.2024.173858_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.ntt.2023.107318","article-title":"Exposure to the pharmaceutical buspirone alters locomotor activity, anxiety-related behaviors, and transcripts related to serotonin signaling in larval zebrafish (Danio rerio)","volume":"101","author":"Biju","year":"2024","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1016\/j.pbb.2024.173858_bb0140","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1097\/00004583-199409000-00009","article-title":"Fluoxetine for childhood anxiety disorders","volume":"33","author":"Birmaher","year":"1994","journal-title":"Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.pbb.2024.173858_bb0145","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/nm741","article-title":"Antidepressant, anxiolytic and anorectic effects of a melanin-concentrating hormone-1 receptor antagonist","volume":"8","author":"Borowsky","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.pbb.2024.173858_bb5015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2024.106712","article-title":"Application of nanofiber-based drug delivery systems in improving anxiolytic effect of new 1,2,3-triazolo-1,4-benzodiazepine derivatives","volume":"195","author":"Botsula","year":"2024","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.pbb.2024.173858_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.108035","article-title":"GABAkines - advances in the discovery, development, and commercialization of positive allosteric modulators of GABAA receptors","volume":"234","author":"Cerne","year":"2022","journal-title":"Pharmacol Ther."},{"key":"10.1016\/j.pbb.2024.173858_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2024.173895","article-title":"Non-sedating anxiolytics","author":"Cerne","year":"2024","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2024.173858_bb0160","article-title":"Melanin-concentrating hormone receptor: A therapeutic target for novel anxiolytics","volume":"Sep;242","author":"Chaki","year":"2024","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2024.173858_bb0165","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1124\/jpet.104.081711","article-title":"Anxiolytic- and antidepressant-like profile of ATC0065 and ATC0175: nonpeptidic and orally active melanin-concentrating hormone receptor 1 antagonists","volume":"313","author":"Chaki","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2024.173858_bb0170","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1527-3458.2005.tb00052.x","article-title":"ATC0175: an orally active melanin-concentrating hormone receptor 1 antagonist for the potential treatment of depression and anxiety","volume":"11","author":"Chaki","year":"2005","journal-title":"CNS Drug Rev."},{"key":"10.1016\/j.pbb.2024.173858_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/157488906775245318","article-title":"Non-monoamine-based approach for the treatment of depression and anxiety disorders","volume":"1","author":"Chaki","year":"2006","journal-title":"Recent Pat. CNS Drug Discov."},{"key":"10.1016\/j.pbb.2024.173858_bb0180","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.pbb.2015.05.018","article-title":"Antidepressant\/anxiolytic potential and adverse effect liabilities of melanin-concentrating hormone receptor 1 antagonists in animal models","volume":"135","author":"Chaki","year":"2015","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"2","key":"10.1016\/j.pbb.2024.173858_bb0185","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1471-4159.2006.04206.x","article-title":"GABAA receptor associated proteins: a key factor regulating GABAA receptor function","volume":"100","author":"Chen","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pbb.2024.173858_bb0190","first-page":"5","article-title":"Pharmacokinetic and pharmacodynamic studies on anxiolytic drug buagafuran","volume":"4","author":"Chen","year":"2013","journal-title":"Med. J. Peking Union Med. Coll. Hosp."},{"key":"10.1016\/j.pbb.2024.173858_bb0195","first-page":"38","article-title":"Electrophysiology mechanisms of 4-butyl-alpha-agarofuran: a new anxiolytic and antidepressant drug","volume":"48","author":"Chen","year":"2013","journal-title":"Yao Xue Xue Bao"},{"key":"10.1016\/j.pbb.2024.173858_bb0200","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/269342a0","article-title":"Chlordiazepoxide selectively augments GABA action in spinal cord cell cultures","volume":"269","author":"Choi","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.pbb.2024.173858_bb0205","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/ddr.430020205","article-title":"Restoration of shock-suppressed behavior by treatment with (+)-5-methyl-10,11-dihydro-5H-dibenzo[a, d]cyclohepten-5, 10-imine (MK-801), a substance with potent anticonvulsant, central sympathomimetic, and apparent anxiolytic properties","volume":"2","author":"Clineschmidt","year":"1982","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.pbb.2024.173858_bb0210","series-title":"Clinicaltrials.gov","author":"ClinicalTrials","year":"2024"},{"key":"10.1016\/j.pbb.2024.173858_bb0215","series-title":"The Benzodiazepines","first-page":"327","article-title":"Effects of behaviorally-active drugs in a conflict-punishment procedure in rats","author":"Cook","year":"1973"},{"issue":"9","key":"10.1016\/j.pbb.2024.173858_bb0220","first-page":"1889","article-title":"Reinforcement schedules and extrapolations to humans from animals in behavioral pharmacology","volume":"34","author":"Cook","year":"1975","journal-title":"Fed. Proc."},{"issue":"2","key":"10.1016\/j.pbb.2024.173858_bb0225","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/fcp.12169","article-title":"Safety profile of etifoxine: a French pharmacovigilance survey","volume":"30","author":"Cottin","year":"2016","journal-title":"Fundam. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.pbb.2024.173858_bb0230","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0149-7634(85)90030-2","article-title":"Exploratory behavior models of anxiety in mice","volume":"9","author":"Crawley","year":"1985","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"12","key":"10.1016\/j.pbb.2024.173858_bb0235","doi-asserted-by":"crossref","first-page":"5897","DOI":"10.1002\/ptr.7999","article-title":"Effect of kava (Piper methysticum) on peripheral gene expression among individuals with generalized anxiety disorder: a post hoc analysis of a randomized controlled trial","volume":"37","author":"Cribb","year":"2023","journal-title":"Phytother. Res."},{"key":"10.1016\/j.pbb.2024.173858_bb0240","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.bbr.2007.10.023","article-title":"The microinjection of AMPA receptor antagonist into the accumbens shell, but not into the accumbens core, induces anxiolysis in an animal model of anxiety","volume":"188","author":"da Cunha","year":"2008","journal-title":"Behav. Brain Res."},{"issue":"5","key":"10.1016\/j.pbb.2024.173858_bb0245","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/cpt1974155473","article-title":"Plasma concentrations of diazepam and of its metabolite N-desmethyldiazepam in relation to anxiolytic effect","volume":"15","author":"Dasberg","year":"1974","journal-title":"Clin. Pharmacol. Ther."},{"issue":"Suppl. 2","key":"10.1016\/j.pbb.2024.173858_bb0250","first-page":"26","article-title":"Use of benzodiazepines in panic disorder","volume":"58","author":"Davidson","year":"1997","journal-title":"J. Clin. Psychiatry"},{"issue":"3","key":"10.1016\/j.pbb.2024.173858_bb0255","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/add.15647","article-title":"Clinical management of the alcohol withdrawal syndrome","volume":"117","author":"Day","year":"2022","journal-title":"Addiction"},{"issue":"453","key":"10.1016\/j.pbb.2024.173858_bb5025","article-title":"Consumption of cashew nut induced anxiolytic-like behavior in dyslipidemic rats consuming a high fat diet","volume":"Sep 13","author":"de Castro Querino Dias","year":"2023","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pbb.2024.173858_bb0260","doi-asserted-by":"crossref","first-page":"117489","DOI":"10.1016\/j.jep.2023.117489","article-title":"Inhaled Litsea glaucescens K. (Lauraceae) leaves\u2019 essential oil has anxiolytic and antidepressant-like activity in mice by BDNF pathway activation","volume":"321","author":"D\u00edaz-Cant\u00f3n","year":"2024","journal-title":"J. Ethnopharmacol."},{"issue":"1","key":"10.1016\/j.pbb.2024.173858_bb0265","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1192\/j.eurpsy.2024.16","article-title":"Baseline symptom severity and efficacy of Silexan in patients with anxiety disorders: a symptom-based, patient-level analysis of randomized, placebo-controlled trials","volume":"67","author":"Dold","year":"2024","journal-title":"Eur. Psychiatry"},{"issue":"3","key":"10.1016\/j.pbb.2024.173858_bb0270","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3109\/10401230209147450","article-title":"The pharmacologic management of SSRI-induced side effects: a survey of psychiatrists","volume":"14","author":"Dording","year":"2002","journal-title":"Ann. Clin. Psychiatry"},{"key":"10.1016\/j.pbb.2024.173858_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbpc.2024.109843","article-title":"JM-20 potently prevents the onset of caffeine-induced anxiogenic phenotypes in zebrafish (Danio rerio)","volume":"277","author":"Dos Santos","year":"2024","journal-title":"Comp Biochem Physiol C Toxicol Pharmacol."},{"key":"10.1016\/j.pbb.2024.173858_bb0280","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1038\/sj.npp.1301531","article-title":"Efficacy and tolerability of an mGlu2\/3 agonist in the treatment of generalized anxiety disorder","volume":"33","author":"Dunayevich","year":"2008","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.pbb.2024.173858_bb0285","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2165\/00003495-198428060-00002","article-title":"A review of its pharmacological properties and therapeutic use","volume":"28","author":"Dundee","year":"1984","journal-title":"Drugs"},{"issue":"316","key":"10.1016\/j.pbb.2024.173858_bb5030","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.bbr.2016.09.028","article-title":"Consequences of constitutive deletion of melanin-concentrating hormone-1 receptors for feeding and foraging behaviors of mice","volume":"Jan 1","author":"Eiler","year":"2017","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pbb.2024.173858_bb0290","doi-asserted-by":"crossref","first-page":"156","DOI":"10.2174\/978160805159511001010156","article-title":"Vasopressin antagonists as anxiolytics and antidepressants: recent developments","volume":"1","author":"Fabio","year":"2010","journal-title":"Frontiers CNS Drug Discov"},{"key":"10.1016\/j.pbb.2024.173858_bb0295","first-page":"81","article-title":"Differential efficacy of memantine for obsessive-compulsive disorder vs. generalized anxiety disorder: an open-label trial","volume":"42","author":"Feusner","year":"2009","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.pbb.2024.173858_bb0300","article-title":"Animal tests of anxiety","author":"File","year":"2005","journal-title":"Curr Protoc Pharmacol"},{"key":"10.1016\/j.pbb.2024.173858_bb0305","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/7854_2016_65","article-title":"Animal models of PTSD: a critical review","volume":"38","author":"Flandreau","year":"2018","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.pbb.2024.173858_bb0310","doi-asserted-by":"crossref","first-page":"114678","DOI":"10.1016\/j.bbr.2023.114678","article-title":"Acute low dose caffeine affects behavior profile and activity, an examination of male rats with high or low anxiety-like behavior","volume":"455","author":"Flor\u00e9n Lind","year":"2023","journal-title":"Behav. Brain Res."},{"issue":"2","key":"10.1016\/j.pbb.2024.173858_bb0315","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00213-023-06490-9","article-title":"Effects of low doses of the novel dehydroepiandrosterone (DHEA) derivative BNN27 in rat models of anxiety","volume":"241","author":"Fragkiadaki","year":"2024","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"10.1016\/j.pbb.2024.173858_bb0320","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/JCP.0000000000001778","article-title":"Treatment of acute intermittent porphyria-associated anxiety disorder with gabapentin: case report and review of literature","volume":"44","author":"Gaba","year":"2024","journal-title":"J Clin Psychopharmacol."},{"key":"10.1016\/j.pbb.2024.173858_bb0325","series-title":"Gabarx.com","author":"GABARx","year":"2024"},{"key":"10.1016\/j.pbb.2024.173858_bb0330","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/BF00429273","article-title":"The effects of meprobamate, barbiturates, d-amphetamine and promazine on experimentally induced conflict in the rat","volume":"1","author":"Geller","year":"1960","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.pbb.2024.173858_bb0335","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/BF00408322","article-title":"Effects of chlordiazepoxide and chlorpromazine on a punishment discrimination","volume":"3","author":"Geller","year":"1962","journal-title":"Psychopharmacologia"},{"issue":"2","key":"10.1016\/j.pbb.2024.173858_bb0340","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3758\/s13415-024-01171-2","article-title":"Rodent tests of depression and anxiety: construct validity and translational relevance","volume":"24","author":"Gencturk","year":"2024","journal-title":"Cogn Affect Behav Neurosci."},{"issue":"7","key":"10.1016\/j.pbb.2024.173858_bb0345","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1038\/s41591-024-03063-x","article-title":"Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial","volume":"30","author":"Glue","year":"2024","journal-title":"Nat. Med."},{"issue":"12B","key":"10.1016\/j.pbb.2024.173858_bb0350","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/0028-3908(83)90118-1","article-title":"Novel non-benzodiazepine anxiolytics","volume":"22","author":"Goldberg","year":"1983","journal-title":"Neuropharmacology"},{"issue":"10","key":"10.1016\/j.pbb.2024.173858_bb5035","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1007\/s00213-023-06437-0","article-title":"The effects of cannabidiol on worry and anxiety among high trait worriers: a double-blind, randomized placebo controlled trial","volume":"Oct;240","author":"Gournay","year":"2023","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"10.1016\/j.pbb.2024.173858_bb0355","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0364-7722(81)90064-3","article-title":"Animal models of anxiety","volume":"5","author":"Gray","year":"1981","journal-title":"Prog. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.pbb.2024.173858_bb0360","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3109\/03602537808993775","article-title":"Dependence, tolerance, and addiction to benzodiazepines: clinical and pharmacokinetic considerations","volume":"8","author":"Greenblatt","year":"1978","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.pbb.2024.173858_bb0365","doi-asserted-by":"crossref","first-page":"6370","DOI":"10.1073\/pnas.092012099","article-title":"Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders","volume":"99","author":"Griebel","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pbb.2024.173858_bb0370","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.4088\/JCP.12m07804","article-title":"The vasopressin V(1b) receptor antagonist SSR149415 in the treatment of major depressive and generalized anxiety disorders: results from 4 randomized, double-blind, placebo-controlled studies","volume":"73","author":"Griebel","year":"2012","journal-title":"J. Clin. Psychiatry"},{"issue":"5\u20136","key":"10.1016\/j.pbb.2024.173858_bb0375","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/BF00449811","article-title":"Pharmacology of the benzodiazepine receptor","volume":"238","author":"Haefely","year":"1989","journal-title":"Eur. Arch. Psychiatry Neurol. Sci."},{"issue":"2","key":"10.1016\/j.pbb.2024.173858_bb0380","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.tins.2020.10.011","article-title":"Regulation of GABAARs by transmembrane accessory proteins","volume":"44","author":"Han","year":"2021","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.pbb.2024.173858_bb0385","doi-asserted-by":"crossref","DOI":"10.1007\/s00213-024-06645-2","article-title":"The effect of SSRIs on unconditioned anxiety: a systematic review and meta-analysis of animal studies","author":"Heesbeen","year":"2024","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2024.173858_bb0390","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/FBP.0b013e32832ec594","article-title":"Anxiolytic-like effects of the neurokinin 1 receptor antagonist GR-205171 in the elevated plus maze and contextual fear-potentiated startle model of anxiety in gerbils","volume":"20","author":"Heldt","year":"2009","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.pbb.2024.173858_bb0395","first-page":"651","article-title":"Anxiolytic and side-effect profile of LY354740: a potent, highly selective, orally active agonist for group II metabotropic glutamate receptors","volume":"284","author":"Helton","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2024.173858_bb0400","doi-asserted-by":"crossref","first-page":"117415","DOI":"10.1016\/j.jep.2023.117415","article-title":"Antidepressant- and anxiolytic-like activities and acute toxicity evaluation of the Psilocybe cubensis mushroom in experimental models in mice","volume":"320","author":"Hernandez-Leon","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.pbb.2024.173858_bb0405","series-title":"Excitatory Amino Acids: Clinical Results with Antagonists","article-title":"2 D-CPPene (SDZ EAA-494)\u2014a competitive NMDA antagonist: pharmacology and results in humans","author":"Herrling","year":"1997"},{"issue":"1","key":"10.1016\/j.pbb.2024.173858_bb0410","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/BF02741459","article-title":"The diversity of GABAA receptors. Pharmacological and electrophysiological properties of GABAA channel subtypes","volume":"18","author":"Hevers","year":"1998","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.pbb.2024.173858_bb0415","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0091-3057(95)02126-4","article-title":"A review of the validity and variability of the elevated plus-maze as an animal model of anxiety","volume":"54","author":"Hogg","year":"1996","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"1","key":"10.1016\/j.pbb.2024.173858_bb0420","doi-asserted-by":"crossref","first-page":"11174","DOI":"10.1038\/s41598-024-61337-3","article-title":"Jnk1 and downstream signalling hubs regulate anxiety-like behaviours in a zebrafish larvae phenotypic screen","volume":"14","author":"Hong","year":"2024","journal-title":"Sci. Rep."},{"issue":"241","key":"10.1016\/j.pbb.2024.173858_bb5040","article-title":"RTI-263, a biased neuropeptide S receptor agonist that retains an anxiolytic effect, attenuates cocaine-seeking behavior in rats","volume":"Dec 15","author":"Huang","year":"2023","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.pbb.2024.173858_bb0425","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/FBP.0000000000000754","article-title":"Minocycline as a potential anxiolytic drug: systematic review and meta-analysis of evidence in murine models","volume":"35","author":"Iglesias","year":"2024","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.pbb.2024.173858_bb5045","article-title":"Cannabinoid type-2 receptors modulate terpene induced anxiety-reduction in zebrafish","volume":"Dec;168","author":"Johnson","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"207","key":"10.1016\/j.pbb.2024.173858_bb5050","article-title":"Leo Sternbach and the benzodiazepines 60 years on: A revolutionary treatment for anxiety disorders","volume":"Jul 25","author":"Junkes","year":"2024","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.pbb.2024.173858_bb0430","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/S0028-3908(97)00130-5","article-title":"Anxiolytic activity of glycine-B antagonists and partial agonists\u2014no relation to intrinsic activity in the patch clamp","volume":"36","author":"Karcz-Kubicha","year":"1997","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2024.173858_bb0435","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/(SICI)1520-6394(1996)4:6<257::AID-DA1>3.0.CO;2-9","article-title":"Onset of antidepressant activity: reexamining the structure of depression and multiple actions of drugs","volume":"4","author":"Katz","year":"1996","journal-title":"Depress. Anxiety"},{"issue":"2\u20133","key":"10.1016\/j.pbb.2024.173858_bb0440","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0167-0115(03)00114-9","article-title":"Behavioural analysis of melanin-concentrating hormone in rats: evidence for orexigenic and anxiolytic properties","volume":"114","author":"Kela","year":"2003","journal-title":"Regul. Pept."},{"key":"10.1016\/j.pbb.2024.173858_bb0445","first-page":"1","article-title":"Determinants of the specificity of behavioral effects of drugs","volume":"60","author":"Kelleher","year":"1968","journal-title":"Ergeb. Physiol."},{"issue":"1","key":"10.1016\/j.pbb.2024.173858_bb0450","first-page":"129","article-title":"Behavioural impacts of following administration of Ficus carica leaves extract in animal model of acute and chronic unpredictable mild stressed exposed rats","volume":"37","author":"Khaliq","year":"2024","journal-title":"Pak. J. Pharm. Sci."},{"issue":"8","key":"10.1016\/j.pbb.2024.173858_bb0455","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.2174\/1389201022666210122125131","article-title":"Anti-anxiety Properties of Selected Medicinal Plants","volume":"23","author":"Khan","year":"2022","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.pbb.2024.173858_bb0460","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.vascn.2013.05.003","article-title":"Animal models of anxiety: a comprehensive review","volume":"68","author":"Kumar","year":"2013","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.pbb.2024.173858_bb0465","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1007\/s00213-021-05861-4","article-title":"The novel vasopressin receptor (V1aR) antagonist SRX246 reduces anxiety in an experimental model in humans: a randomized proof-of-concept study","volume":"238","author":"Lago","year":"2021","journal-title":"Psychopharmacology (Berl)"},{"issue":"3","key":"10.1016\/j.pbb.2024.173858_bb0470","first-page":"379","article-title":"Benincasa hispida alleviates stress and anxiety in a zebrafish (Danio rerio) model","volume":"14","author":"Lakshmanagowda","year":"2024","journal-title":"Life (Basel)."},{"key":"10.1016\/j.pbb.2024.173858_bb0475","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187671","article-title":"Agomelatine, venlafaxine, and running exercise effectively prevent anxiety- and depression-like behaviors and memory impairment in restraint stressed rats","volume":"12","author":"Lapmanee","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.pbb.2024.173858_bb0480","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3389\/fnsys.2013.00100","article-title":"A novel V1a receptor antagonist blocks vasopressin-induced changes in the CNS response to emotional stimuli: an fMRI study","volume":"7","author":"Lee","year":"2013","journal-title":"Front. Syst. Neurosci."},{"issue":"3","key":"10.1016\/j.pbb.2024.173858_bb0485","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202302122","article-title":"Molecular docking and GC\/MS-based approach for identification of anxiolytic alkaloids from Griffinia (Amaryllidaceae) species in a zebrafish model","volume":"21","author":"Leite","year":"2024","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.pbb.2024.173858_bb0490","first-page":"881","article-title":"New stereoselective synthesis of 4-butyl-\u03b1-agarofuran","volume":"14","author":"Li","year":"2003","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.pbb.2024.173858_bb0495","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1527-3458.2005.tb00034.x","article-title":"The pharmacology of DMP696 and DMP904, non-peptidergic CRF1 receptor antagonists","volume":"11","author":"Li","year":"2005","journal-title":"CNS Drug Rev."},{"key":"10.1016\/j.pbb.2024.173858_bb0500","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1016\/j.lfs.2005.08.002","article-title":"Decreases in nestlet shredding of mice by serotonin uptake inhibitors: comparison with marble burying","volume":"78","author":"Li","year":"2006","journal-title":"Life Sci."},{"key":"10.1016\/j.pbb.2024.173858_bb0505","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.cclet.2013.03.048","article-title":"Absolute configuration of Buagafuran: an experimental and theoretical electronic circular dichroism study","volume":"24","author":"Li","year":"2013","journal-title":"Chin. Chem. Lett."},{"issue":"1","key":"10.1016\/j.pbb.2024.173858_bb0510","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1176\/ajp.136.1.18","article-title":"Relationship of plasma levels of chlordiazepoxide and metabolites to clinical response","volume":"136","author":"Lin","year":"1979","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.pbb.2024.173858_bb0515","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0091-3057(79)90304-6","article-title":"A synthetic non-benzodiazepine ligand for benzodiazepine receptors: a probe for investigating neuronal substrates of anxiety","volume":"11","author":"Lippa","year":"1979","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2024.173858_bb0520","first-page":"125","article-title":"Synthesis and CNS activities of \u03b1-agrofuran derivatives","volume":"13","author":"Liu","year":"2003","journal-title":"Chin. J. Med. Chem."},{"issue":"11","key":"10.1016\/j.pbb.2024.173858_bb0525","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1523\/JNEUROSCI.03-11-02270.1983","article-title":"Two distinct solubilized benzodiazepine receptors: differential modulation by ions","volume":"3","author":"Lo","year":"1983","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pbb.2024.173858_bb0530","doi-asserted-by":"crossref","first-page":"8322844","DOI":"10.1155\/2024\/8322844","article-title":"Pharmacological manipulation of corticotropin-releasing factor receptors in the anterior and posterior subregions of the insular cortex differently affects anxiety-like behaviors in the elevated plus maze in rats","volume":"2024","author":"Lopes","year":"2024","journal-title":"Biomed. Res. Int."},{"issue":"9","key":"10.1016\/j.pbb.2024.173858_bb0535","doi-asserted-by":"crossref","first-page":"4149","DOI":"10.1002\/ptr.7876","article-title":"11-Ethoxyviburtinal improves chronic restraint stress-induced anxiety-like behaviors in gender-specific mice via PI3K\/Akt and E2\/ER\u03b2 signaling pathways","volume":"37","author":"Lyu","year":"2023","journal-title":"Phytother. Res."},{"key":"10.1016\/j.pbb.2024.173858_bb5060","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainresbull.2023.110768","article-title":"The Anxiolytic Effect of Polysaccharides from Stellariae Radix through Monoamine Neurotransmitters, HPA Axis, and ECS\/ERK\/CREB\/BDNF Signaling Pathway in Stress-induced Male Rats","volume":"203","author":"Ma","year":"2023","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.pbb.2024.173858_bb0540","doi-asserted-by":"crossref","first-page":"118013","DOI":"10.1016\/j.jep.2024.118013","article-title":"Glycyrrhizic acid treatment ameliorates anxiety-like behaviour via GLT1 and Per1\/2-dependent pathways","volume":"328","author":"Ma","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.pbb.2024.173858_bb0545","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2023.173651","article-title":"Anxiolytic-like action of 3-((4-methoxyphenyl)selanyl)-2-phenylbenzofuran (SeBZF3) in mice: a possible contribution of the serotonergic system","volume":"232","author":"Magalh\u00e3es","year":"2023","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"14","key":"10.1016\/j.pbb.2024.173858_bb0550","doi-asserted-by":"crossref","first-page":"678","DOI":"10.12968\/bjon.2023.32.14.678","article-title":"A clinical review of antidepressants, their sexual side-effects, post-SSRI sexual dysfunction, and serotonin syndrome","volume":"32","author":"Marks","year":"2023","journal-title":"Br. J. Nurs."},{"issue":"7740","key":"10.1016\/j.pbb.2024.173858_bb0555","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41586-018-0832-5","article-title":"GABAA receptor signalling mechanisms revealed by structural pharmacology","volume":"565","author":"Masiulis","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.pbb.2024.173858_bb0560","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.bbr.2018.11.019","article-title":"Effects of 5-HT7 receptor antagonists on behaviors of mice that detect drugs used in the treatment of anxiety, depression, or schizophrenia","volume":"359","author":"Maxwell","year":"2019","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pbb.2024.173858_bb0565","series-title":"Behavioral Pharmacology","first-page":"85","article-title":"Effects of drugs on schedule-controlled behavior","author":"McMillan","year":"1976"},{"key":"10.1016\/j.pbb.2024.173858_bb0570","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1192\/bjp.179.6.514","article-title":"Efficacy of usual antidepressant dosing regimens of fluoxetine in panic disorder: randomised, placebo-controlled trial","volume":"179","author":"Michelson","year":"2001","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.pbb.2024.173858_bb0575","series-title":"FDA Clears MindMed IND for MM-120 in Treatment of Generalized Anxiety Disorder","author":"MindMed","year":"2024"},{"key":"10.1016\/j.pbb.2024.173858_bb0580","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1126\/science.918669","article-title":"Benzodiazepine receptor: demonstration in the central nervous system","volume":"198","author":"M\u00f6hler","year":"1977","journal-title":"Science"},{"key":"10.1016\/j.pbb.2024.173858_bb0585","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110520","article-title":"Potential anxiolytic and antidepressant-like effects of luteolin in a chronic constriction injury rat model of neuropathic pain: Role of oxidative stress, neurotrophins, and inflammatory factors","volume":"122","author":"Mokhtari","year":"2023","journal-title":"Int Immunopharmacol."},{"key":"10.1016\/j.pbb.2024.173858_bb0590","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/BF00413158","article-title":"Effect of amobarbital and chlorpromazine on punished behavior in the pigeon","volume":"6","author":"Morse","year":"1964","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.pbb.2024.173858_bb0595","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1161\/01.STR.26.3.503","article-title":"Clinical experience with excitatory amino acid antagonist drugs","volume":"26","author":"Muir","year":"1995","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.pbb.2024.173858_bb5065","first-page":"220","article-title":"Synergistic anxiolytic efficacy exploring the combined effects of diazepam and zinc chloride in wistar albino rats","volume":"Jun;74","author":"Naik","year":"2024","journal-title":"Drug Res. (Stuttg)."},{"issue":"3","key":"10.1016\/j.pbb.2024.173858_bb0600","doi-asserted-by":"crossref","DOI":"10.1002\/jnr.25306","article-title":"Repeated finasteride administration promotes synaptic plasticity and produces antidepressant- and anxiolytic-like effects in female rats","volume":"102","author":"Nayana","year":"2024","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.pbb.2024.173858_bb0605","series-title":"nimh.nih.gov\/health\/statistics\/any-anxiety-disorder","author":"NIMH","year":"2024"},{"key":"10.1016\/j.pbb.2024.173858_bb0610","series-title":"nimh.nih.gov\/health\/topics\/anxiety-disorders","author":"NIMH","year":"2024"},{"issue":"10","key":"10.1016\/j.pbb.2024.173858_bb0615","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.3390\/nu16101527","article-title":"Indulging curiosity: preliminary evidence of an anxiolytic-like effect of castor oil and ricinoleic acid","volume":"16","author":"Nisbett","year":"2024","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.pbb.2024.173858_bb0620","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1365-2826.2011.02166.x","article-title":"Translocator protein (18 kDa) as a target for novel anxiolytics with a favourable side-effect profile","volume":"24","author":"Nothdurfter","year":"2012","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.pbb.2024.173858_bb0625","doi-asserted-by":"crossref","first-page":"118271","DOI":"10.1016\/j.jep.2024.118271","article-title":"Chemical profiling, anticonvulsant and anxiolytic effects of the smoke constituents isolated from Leonotis leonurus (L.) R.Br","volume":"331","author":"Nsuala","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.pbb.2024.173858_bb0630","doi-asserted-by":"crossref","first-page":"109836","DOI":"10.1016\/j.neuropharm.2024.109836","article-title":"BNC210, a negative allosteric modulator of the alpha 7 nicotinic acetylcholine receptor, demonstrates anxiolytic- and antidepressant-like effects in rodents","volume":"246","author":"O\u2019Connor","year":"2024","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.pbb.2024.173858_bb0635","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0924-977X(94)90002-7","article-title":"New animal models of anxiety","volume":"4","author":"Olivier","year":"1994","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.pbb.2024.173858_bb0640","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.neuropharm.2008.07.045","article-title":"GABA a receptors: subtypes provide diversity of function and pharmacology","volume":"56","author":"Olsen","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2024.173858_bb0645","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1001\/archpsyc.1973.01750360007002","article-title":"National patterns of psychotherapeutic drug use","volume":"28","author":"Parry","year":"1973","journal-title":"Arch. Gen. Psychiatry"},{"issue":"5","key":"10.1016\/j.pbb.2024.173858_bb0650","article-title":"Anxiolytic potential of resveratrol and rufinamide combination by modulating GABA-ergic transmission: insights from experiments, molecular docking and dynamics simulations","volume":"74","author":"Parveen","year":"2023","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.pbb.2024.173858_bb0655","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/00004714-200102000-00008","article-title":"Augmentation of fluoxetine\u2019s antidepressant action by pindolol: analysis of clinical, pharmacokinetic, and methodologic factors","volume":"21","author":"Perez","year":"2001","journal-title":"J. Clin. Psychopharmacol."},{"issue":"6292","key":"10.1016\/j.pbb.2024.173858_bb0660","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1136\/bmj.283.6292.643","article-title":"Withdrawal from long-term benzodiazepine treatment","volume":"283","author":"Petursson","year":"1981","journal-title":"Br. Med. J. (Clin. Res. Ed)"},{"issue":"6","key":"10.1016\/j.pbb.2024.173858_bb0665","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.3390\/molecules29061411","article-title":"Nitric oxide (NO) synthase inhibitors: potential candidates for the treatment of anxiety disorders?","volume":"29","author":"Pitsikas","year":"2024","journal-title":"Molecules"},{"issue":"sup1","key":"10.1016\/j.pbb.2024.173858_bb0670","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1080\/15622975.2018.1468030","article-title":"Anxiolytics targeting GABAA receptors: insights on etifoxine","volume":"19","author":"Poisbeau","year":"2018","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.pbb.2024.173858_bb0675","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1124\/jpet.105.089839","article-title":"Fenobam: a clinically validated nonbenzodiazepine anxiolytic is a potent, selective, and noncompetitive mGlu5 receptor antagonist with inverse agonist activity","volume":"315","author":"Porter","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2024.173858_bb0680","author":"Pubmed"},{"issue":"12","key":"10.1016\/j.pbb.2024.173858_bb0685","doi-asserted-by":"crossref","first-page":"6189","DOI":"10.1021\/acs.jafc.3c05718","article-title":"Potential mechanisms of casein hexapeptide YPVEPF on stress-induced anxiety and insomnia mice and its molecular effects and key active structure","volume":"72","author":"Qian","year":"2024","journal-title":"J. Agric. Food Chem."},{"issue":"3","key":"10.1016\/j.pbb.2024.173858_bb0690","first-page":"1202","article-title":"Bark extract of Chaetocarpus castanocarpus (Roxb.) exhibits potent sedative, anxiolytic, and antidepressant effects through an in vivo approach in Swiss albino mice","volume":"28","author":"Rahman","year":"2024","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.pbb.2024.173858_bb0695","first-page":"163","article-title":"The psychosedative properties of methaminodiazepoxide","volume":"129","author":"Randall","year":"1960","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"9","key":"10.1016\/j.pbb.2024.173858_bb0700","first-page":"590","article-title":"Pharmacology of the metabolites of chlordiazepoxide and diazepam","volume":"7","author":"Randall","year":"1965","journal-title":"Curr. Ther. Res. Clin. Exp."},{"key":"10.1016\/j.pbb.2024.173858_bb0705","first-page":"237","article-title":"The use of MK-801, a novel sympathomimetic, in adults with attention deficit disorder, residual type","volume":"22","author":"Reimherr","year":"1986","journal-title":"Psychopharmacol. Bull."},{"issue":"1","key":"10.1016\/j.pbb.2024.173858_bb0710","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lfs.2014.08.002","article-title":"Animal models of social anxiety disorder and their validity criteria","volume":"114","author":"R\u00e9us","year":"2014","journal-title":"Life Sci."},{"issue":"6\u20137","key":"10.1016\/j.pbb.2024.173858_bb0715","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/00008877-199711000-00003","article-title":"Animal models of \u2018anxiety\u2019: where next?","volume":"8","author":"Rodgers","year":"1997","journal-title":"Behav. Pharmacol."},{"issue":"5","key":"10.1016\/j.pbb.2024.173858_bb0720","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1001\/jamapsychiatry.2017.0056","article-title":"Cross-sectional comparison of the epidemiology of DSM-5 generalized anxiety disorder across the globe","volume":"74","author":"Ruscio","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.pbb.2024.173858_bb0725","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1097\/00000542-199811000-00005","article-title":"AMPA\/kainate antagonist LY293558 reduces capsaicin-evoked hyperalgesia but not pain in normal skin in humans","volume":"89","author":"Sang","year":"1998","journal-title":"Anesthesiology"},{"issue":"3","key":"10.1016\/j.pbb.2024.173858_bb0730","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0031-9384(87)90359-3","article-title":"The behavioral profile of zolpidem, a novel hypnotic drug of imidazopyridine structure","volume":"41","author":"Sanger","year":"1987","journal-title":"Physiol. Behav."},{"issue":"2","key":"10.1016\/j.pbb.2024.173858_bb0735","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0278-5846(91)90082-C","article-title":"Animal models of anxiety and the development of novel anxiolytic drugs","volume":"15","author":"Sanger","year":"1991","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"14","key":"10.1016\/j.pbb.2024.173858_bb5070","doi-asserted-by":"crossref","first-page":"5314","DOI":"10.3390\/molecules28145314","article-title":"Coriandrum sativum and Its Utility in Psychiatric Disorders","volume":"Jul 10;28","author":"Santib\u00e1\u00f1ez","year":"2023","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.pbb.2024.173858_bb5080","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/fcp.12960","article-title":"Synthesis, molecular docking, ADMET, and evaluation of the anxiolytic effect in adult zebrafish of synthetic chalcone (E)-3-(4-(dimethylamino)phenyl)-1-(2-hydroxyphenyl)prop-2-en-1-one: An in vivo and in silico approach","volume":"Apr;38","author":"Santos Oliveira","year":"2024","journal-title":"Fundam. Clin. Pharmacol."},{"issue":"21","key":"10.1016\/j.pbb.2024.173858_bb0740","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.3390\/nu15214586","article-title":"Neuroimaging insights: Kava\u2019s (Piper methysticum) effect on dorsal anterior cingulate cortex GABA in generalized anxiety disorder","volume":"15","author":"Savage","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.pbb.2024.173858_bb0745","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000401211","article-title":"Neuropharmacology of sedatives and anxiolytics","volume":"14","author":"Schallek","year":"1979","journal-title":"Mod. Probl. Pharmacopsychiatry"},{"issue":"Pt 3","key":"10.1016\/j.pbb.2024.173858_bb5085","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.neubiorev.2014.10.002","article-title":"Translational approach to studying panic disorder in rats: hits and misses","volume":"Oct;46","author":"Schenberg","year":"2014","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.pbb.2024.173858_bb0750","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2024.173826","article-title":"mGlu2\/3 receptors (LY354740) in anxiety","author":"Schoepp","year":"2024","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2024.173858_bb0755","series-title":"Psychopharmacology: A Biochemical and Behavioral Approach","author":"Seiden","year":"1980"},{"key":"10.1016\/j.pbb.2024.173858_bb5090","article-title":"Neuroprotective anticonvulsant and anxiolytic effects of octreotide in wistar rats","volume":"Oct;132","author":"Shayan","year":"2023","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.pbb.2024.173858_bb0760","doi-asserted-by":"crossref","first-page":"115859","DOI":"10.1016\/j.biopha.2023.115859","article-title":"Regulation of anxiety-like behaviors by S-palmitoylation and S-nitrosylation in basolateral amygdala","volume":"169","author":"Shen","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"10","key":"10.1016\/j.pbb.2024.173858_bb0765","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2165\/00023210-200620100-00002","article-title":"Melanin-concentrating hormone MCH1 receptor antagonists: a potential new approach to the treatment of depression and anxiety disorders","volume":"20","author":"Shimazaki","year":"2006","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/j.pbb.2024.173858_bb0770","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/14656566.2024.2308678","article-title":"Buspirone for the treatment of anxiety in Williams syndrome: a retrospective chart review study","volume":"25","author":"Shin","year":"2024","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.pbb.2024.173858_bb0775","doi-asserted-by":"crossref","first-page":"137723","DOI":"10.1016\/j.neulet.2024.137723","article-title":"Cannabidiol exhibits anxiolytic-like effects and antipsychotic-like effects in mice models","volume":"826","author":"Shu","year":"2024","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pbb.2024.173858_bb0780","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.tips.2012.08.003","article-title":"Anxioselective anxiolytics: on a quest for the holy grail","volume":"33","author":"Skolnick","year":"2012","journal-title":"Trends Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.pbb.2024.173858_bb0785","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0014-2999(80)90222-8","article-title":"Pentobarbital potentiates GABA-enhanced [3H]-diazepam binding to benzodiazepine receptors","volume":"65","author":"Skolnick","year":"1980","journal-title":"Eur. J. Pharmacol."},{"issue":"9","key":"10.1016\/j.pbb.2024.173858_bb0790","first-page":"416","article-title":"Suspected dependence on chlordiazepoxide hydrochloride (Librium)","volume":"95","author":"Slater","year":"1966","journal-title":"Can. Med. Assoc. J."},{"key":"10.1016\/j.pbb.2024.173858_bb0795","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S0140-6736(18)31793-8","article-title":"Pharmacological treatments for generalised anxiety disorder: a systematic review and network meta-analysis","volume":"393","author":"Slee","year":"2019","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.pbb.2024.173858_bb0800","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/sj.npp.1300913","article-title":"Melanin-concentrating hormone-1 receptor modulates neuroendocrine, behavioral, and corticolimbic neurochemical stress responses in mice","volume":"31","author":"Smith","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2024.173858_bb0805","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1007\/s00213-017-4556-2","article-title":"Don\u2019t stress about CRF: assessing the translational failures of CRF1 antagonists","volume":"234","author":"Spierling","year":"2017","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2024.173858_bb0810","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/266732a0","article-title":"Benzodiazepine receptors in rat brain","volume":"266","author":"Squires","year":"1977","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.pbb.2024.173858_bb0815","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF01965860","article-title":"The discovery of librium","volume":"2","author":"Sternbach","year":"1972","journal-title":"Agents Actions"},{"issue":"1","key":"10.1016\/j.pbb.2024.173858_bb0820","doi-asserted-by":"crossref","first-page":"11519","DOI":"10.1038\/s41598-024-62309-3","article-title":"Anxiolytic effects of Enterococcus faecalis 2001 on a mouse model of colitis","volume":"14","author":"Takahashi","year":"2024","journal-title":"Sci. Rep."},{"issue":"4428","key":"10.1016\/j.pbb.2024.173858_bb0825","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1126\/science.6101294","article-title":"Receptors for the age of anxiety: pharmacology of the benzodiazepines","volume":"207","author":"Tallman","year":"1980","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.pbb.2024.173858_bb0830","first-page":"1823","article-title":"Anxiolytic interventions of extracts and pure compounds from Adenanthera pavonina and Peltophorum pterocarpum leaves to treat acute anxiety and depression symptoms in mice","volume":"36","author":"Tasleem","year":"2023","journal-title":"Pak. J. Pharm. Sci."},{"key":"10.1016\/j.pbb.2024.173858_bb0835","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1177\/070674370505000702","article-title":"Listening to the past: history, psychiatry, and anxiety","volume":"50","author":"Tone","year":"2005","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.pbb.2024.173858_bb0840","series-title":"The Age of Anxiety: A History of America\u2019s Turbulent Affair With Tranquilizers","author":"Tone","year":"2009"},{"issue":"7","key":"10.1016\/j.pbb.2024.173858_bb0845","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1038\/s41591-024-03057-9","article-title":"Personalized brain circuit scores identify clinically distinct biotypes in depression and anxiety","volume":"30","author":"Tozzi","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.pbb.2024.173858_bb0850","author":"Tranquilizer"},{"issue":"2","key":"10.1016\/j.pbb.2024.173858_bb0855","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0149-7634(85)90046-6","article-title":"Animal models for the study of anti-anxiety agents: a review","volume":"9","author":"Treit","year":"1985","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.pbb.2024.173858_bb0865","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0014-2999(91)90894-V","article-title":"1-Aminocyclopropanecarboxylates exhibit antidepressant and anxiolytic actions in animal models","volume":"203","author":"Trullas","year":"1991","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2024.173858_bb0870","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107809","article-title":"The pro-psychotic metabotropic glutamate receptor compounds fenobam and AZD9272 share binding sites with monoamine oxidase-B inhibitors in humans","volume":"162","author":"Varn\u00e4s","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2024.173858_bb0875","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2023.173654","article-title":"Involvement of the serotoninergic system in the anxiolytic action mechanism of a liposomal formulation containing nimodipine (NMD-Lipo)","volume":"232","author":"Viana","year":"2023","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"1","key":"10.1016\/j.pbb.2024.173858_bb0880","doi-asserted-by":"crossref","first-page":"9799","DOI":"10.1038\/s41598-024-58877-z","article-title":"Network pharmacology combined with molecular docking and experimental verification to elucidate the effect of flavan-3-ols and aromatic resin on anxiety","volume":"14","author":"Vikhar Danish Ahmad","year":"2024","journal-title":"Sci Rep."},{"key":"10.1016\/j.pbb.2024.173858_bb0885","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00403989","article-title":"A simple and reliable conflict procedure for testing antianxiety agents","volume":"21","author":"Vogel","year":"1971","journal-title":"Psychopharmacologia"},{"issue":"11","key":"10.1016\/j.pbb.2024.173858_bb0890","doi-asserted-by":"crossref","first-page":"9580","DOI":"10.3390\/ijms24119580","article-title":"Pharmacological analysis of GABAA receptor and Sigma1R chaperone interaction: research report I-investigation of the anxiolytic, anticonvulsant and hypnotic effects of allosteric GABAA receptors\u2019 ligands","volume":"24","author":"Voronin","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.pbb.2024.173858_bb0895","first-page":"1745","article-title":"Management of common anxiety disorders","volume":"50","author":"Walley","year":"1994","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.pbb.2024.173858_bb0900","first-page":"110","article-title":"Tolerance and safety of buagafuran in Chinese healthy volunteers","volume":"20","author":"Wang","year":"2011","journal-title":"Chin. J. New Drugs"},{"key":"10.1016\/j.pbb.2024.173858_bb0905","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2023.173588","article-title":"Anxiolytic-like effects of an mGluR 5 antagonist and a mGluR 2\/3 agonist, and antidepressant-like effects of an mGluR 7 agonist in the chick social separation stress test, a dual-drug screening model of treatment-resistant depression","volume":"227-228","author":"White","year":"2023","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2024.173858_bb0910","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1517\/13543784.2013.803066","article-title":"Glutamate-based anxiolytic ligands in clinical trials","volume":"22","author":"Wiero\u0144ska","year":"2013","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.pbb.2024.173858_bb0915","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0165-6147(90)90150-7","article-title":"The behavioral pharmacology of NMDA receptor antagonists","volume":"11","author":"Willetts","year":"1990","journal-title":"Trends Pharmacol. Sci."},{"issue":"6\u20137","key":"10.1016\/j.pbb.2024.173858_bb0920","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/00008877-199711000-00001","article-title":"The behavioural pharmacology of anxiety and depression","volume":"8","author":"Willner","year":"1997","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.pbb.2024.173858_bb0925","series-title":"Accidental Medical Discoveries: How Tenacity and Pure Dumb Luck Changed the World","author":"Winters","year":"2016"},{"issue":"1","key":"10.1016\/j.pbb.2024.173858_bb0930","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2174\/1871527314666150130154757","article-title":"Commentary: obstacles to the discovery of medicines for psychiatric disorders in modern times","volume":"14","author":"Witkin","year":"2015","journal-title":"CNS Neurol. Disord. Drug Targets"},{"issue":"5","key":"10.1016\/j.pbb.2024.173858_bb0935","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/0091-3057(76)90265-3","article-title":"Effects of pentobarbital on punished behavior at different shock intensities","volume":"5","author":"Witkin","year":"1976","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"17","key":"10.1016\/j.pbb.2024.173858_bb0940","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/0024-3205(85)90477-1","article-title":"Behavioral effects and benzodiazepine antagonist activity of Ro 15-1788 (flumazepil) in pigeons","volume":"37","author":"Witkin","year":"1985","journal-title":"Life Sci."},{"key":"10.1016\/j.pbb.2024.173858_bb0945","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/ddr.430200312","article-title":"Analysis of behavioral effects of drugs","volume":"20","author":"Witkin","year":"1990","journal-title":"Drug Dev. Res."},{"issue":"3","key":"10.1016\/j.pbb.2024.173858_bb0950","first-page":"247","article-title":"Comparison of effects of buspirone and gepirone with benzodiazepines and antagonists of dopamine and serotonin receptors on punished behavior of rats","volume":"1","author":"Witkin","year":"1989","journal-title":"Behav. Pharmacol."},{"issue":"1","key":"10.1016\/j.pbb.2024.173858_bb0955","first-page":"1","article-title":"Effects of methaqualone on punished and nonpunished behavior","volume":"218","author":"Witkin","year":"1981","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2024.173858_bb0960","series-title":"Burger\u2019s Medicinal Chemistry, Drug Discovery and Development","article-title":"New and emerging antiepileptic drugs","author":"Witkin","year":"2021"},{"key":"10.1016\/j.pbb.2024.173858_bb0965","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2021.173321","article-title":"The imidazodiazepine, KRM-II-81: an example of a newly emerging generation of GABAkines for neurological and psychiatric disorders","volume":"213","author":"Witkin","year":"2022","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"2","key":"10.1016\/j.pbb.2024.173858_bb0970","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/BF02245824","article-title":"Current benzodiazepine issues","volume":"118","author":"Woods","year":"1995","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"10.1016\/j.pbb.2024.173858_bb0975","first-page":"151","article-title":"Benzodiazepines: use, abuse, and consequences","volume":"44","author":"Woods","year":"1992","journal-title":"Pharmacol. Rev."},{"issue":"2","key":"10.1016\/j.pbb.2024.173858_bb0980","first-page":"397","article-title":"Effects of some benzodiazepines on punished and unpunished behavior in the pigeon","volume":"172","author":"Wuttke","year":"1970","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2024.173858_bb0985","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/0091-3057(94)00428-L","article-title":"Anticonflict effect of MK-801 in rats: time course and chronic treatment studies","volume":"51","author":"Xie","year":"1995","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"2","key":"10.1016\/j.pbb.2024.173858_bb0990","first-page":"307","article-title":"Dependence liability of several sedative-hypnotic agents evaluated in monkeys","volume":"185","author":"Yanagita","year":"1973","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2024.173858_bb0995","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jpba.2012.11.033","article-title":"Simultaneous determination of a novel anxiolytic agent buagafuran and one metabolite in human plasma by ultra-performance liquid chromatography-tandem mass spectrometry","volume":"76","author":"Yang","year":"2013","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.pbb.2024.173858_bb1000","doi-asserted-by":"crossref","first-page":"683","DOI":"10.3389\/fphar.2017.00683","article-title":"Prediction of a therapeutic dose for buagafuran, a potent anxiolytic agent by physiologically based pharmacokinetic\/pharmacodynamic modeling starting from pharmacokinetics in rats and human","volume":"8","author":"Yang","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.pbb.2024.173858_bb1005","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.2174\/1389450118666171117131151","article-title":"Vortioxetine treatment for anxiety disorder: a meta-analysis study","volume":"19","author":"Yee","year":"2018","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.pbb.2024.173858_bb1010","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ejphar.2004.09.051","article-title":"Effects of novel anxiolytic 4-butyl-alpha-agarofuran on levels of monoamine neurotransmitters in rats","volume":"504","author":"Zhang","year":"2004","journal-title":"Eur. J. Pharmacol."}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305724001527?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305724001527?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T13:51:12Z","timestamp":1733233872000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305724001527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":215,"alternative-id":["S0091305724001527"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2024.173858","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ANXIOLYTICS: Origins, drug discovery, and mechanisms","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2024.173858","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"173858"}}